ASHP InterSections ASHP InterSections

April 9, 2020

Important Wins on the Advocacy Front in the Fight Against COVID-19

Dear Colleagues,

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

AS THE IMPACT OF THE COVID-19 PANDEMIC CONTINUES TO ESCALATE ACROSS THE COUNTRY, there is increased urgency to ensure that frontline pharmacists, pharmacy technicians, and our healthcare partners have the medications and equipment they need to successfully treat their patients. ASHP continues to spearhead multiple advocacy efforts that support your ability to provide the best care possible for those in need.

Mitigating shortages of critical medications like propofol, fentanyl, midazolam, paralytics, and others remains a high priority. We continue to engage with relevant federal agencies to improve access to medications. I am pleased to report that the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA) have taken critical actions in direct response to ASHP’s advocacy efforts.

ASHP, in coordination with the American Medical Association, the American Hospital Association, the Association for Clinical Oncology, and the American Society of Anesthesiologists, sent a letter last week to the DEA requesting an immediate increase in the annual production quota allocations for Schedule II controlled substances. This would enable manufacturers and 503B outsourcing facilities to increase the supply of opioids critical to the care of COVID-19 patients on ventilators. As a direct result of this collaborative advocacy effort, the DEA announced yesterday that it is taking immediate actions to address this critical issue. These actions include increasing the annual production quota for controlled substances, including fentanyl, morphine, and hydromorphone, that are used for the treatment of mechanically ventilated COVID-19 patients, and increasing the amount of ketamine, diazepam, and other controlled substances that can be imported into the United States.

We also sent a letter to the FDA advocating for regulatory flexibility in compounding drugs in shortage and compounding in hospitals. ASHP’s advocacy efforts, including significant staff engagement on the issue, directly triggered the FDA to clarify existing compounding guidance, including the removal of the one-mile radius requirement for hospitals compounding medications. FDA’s quick action to reduce regulatory hurdles for health systems is an important step to help clarify compounding guidance during this crisis.

ASHP will continue to advocate for additional compounding flexibility, including the expansion of FDA’s drug shortage list to include products ASHP has identified as in shortage. We will also continue to seek 503B outsourcing facility flexibility, particularly for hospital-owned or affiliated 503B operations, to help ensure they can meet hospitals’ medication needs.

Yesterday, we were pleased to see that the Department of Health and Human Services (HHS) authorized pharmacists to order and administer COVID-19 tests pursuant to the Public Readiness and Emergency Preparedness (PREP) Act. The authorization is responsive to the joint COVID-19 recommendations we created with other national organizations. While this authorization does not address pharmacist reimbursement, we are encouraged to see HHS providing pharmacists with a greater role in supporting the COVID-19 response, and we continue to work on that issue.

We also continue to actively advocate for Congress to recognize pharmacists as providers in the Medicare program to further support the COVID-19 response and beyond. Yesterday, ASHP and 11 other national organizations sent a letter requesting that Congress immediately support legislation that would establish pharmacists as providers in Medicare Part B on an emergency basis to provide COVID-19 and flu testing. This authority is an important step in being able to rapidly expand access to testing across our country to support the national response to this crisis. We also see this as a step toward expanded recognition of pharmacists by payers, including Medicare.

Finally, ASHP is also working with our members and other stakeholders to gain access to medications from the Strategic National Stockpile (SNS). Most recently, we joined with several organizations to request that FEMA immediately release all available quantities of a number of critical drugs from the SNS to the New York and New Jersey Departments of Health to address urgent patient care needs. We are also working to support other state affiliates and members across the country with these important requests.

ASHP and its government relations team will continue to work tirelessly with our collaborating partners to ensure that U.S. regulatory authorities are responding to the current needs of pharmacists and healthcare providers.

While our collective attention is on the needs of frontline practitioners, I wanted to take an opportunity to highlight some positive news about the newest members of our profession. ASHP’s 2020 Residency Match concluded this week, and I want to congratulate the 5,269 future pharmacists who matched with 2,551 PGY1 and PGY2 pharmacy residency programs across the country. This number represents a 46% increase in the number of available positions over the past five years – a remarkable rate of growth. I am pleased that our accredited residency programs have demonstrated an outstanding commitment to training during the pandemic. While managing multiple critical priorities, these programs continued to interview applicants virtually. This undoubtedly will be a unique time during which to begin a residency program regardless of its focus. ASHP is committed to ensuring that these young practitioners and their programs have the needed resources to successfully conduct critically important resident training this year and beyond.

In the same vein, please know that ASHP stands ready to offer you and your healthcare colleagues that same level of steadfast support. In addition to advocating to give you access to critical medications, ASHP continues to update and create new resources and tools that can be found on our COVID-19 Resource Center. We have also opened access to many evidence-based online resources and tools on ashp.org, making them widely available to all pharmacists and the broader healthcare community.

Over the last few weeks, I have heard countless stories from members and others about the challenges they are facing, but I’ve also heard many stories of hope and heroism. I, and David Chen, ASHP assistant vice president for Pharmacy Leadership and Planning, have listened in on calls from pharmacy leaders at major health systems in New York City, the pandemic’s current epicenter. We are incredibly impressed by how these leaders have shared their information and experiences and how they support each other and their frontline staff. This is a tremendous example of how peer-to-peer connection and communication can aid in the pandemic response. Their experiences and willingness to share their stories will undoubtedly help others in responding to COVID-19 in facilities across the country. We applaud them for these efforts.

Please also know that ASHP is here to support your well-being, which should remain a priority for all healthcare personnel during this challenging time. Please make sure that you are taking care of yourself and your family.

“ASHP has our backs.” These are the words of a member who recently reached out to us. This really resonated with me, and I can assure you that we will continue to work across all fronts, leveraging our talented staff, our valued partners, and our amazing members to provide you with the information, connections, and resources you need today and in the future.

Thank you for everything you do for your patients and the profession.

Sincerely,

Paul

March 17, 2017

Residency Match Day 2017

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

CONGRATULATIONS TO ALL WHO MATCHED during Phase I of the residency Match! If you didn’t match in the first round, please plan to participate in Phase II, as there are still a number of unfilled positions at excellent programs all across the country.

This year’s Match was another remarkable success. There were 5,752 applicants this year for 4,592 residency positions. Of those total positions, 3,750 are now filled with the remainder to be filled in Phase II of the Match. It should be noted that over the last five years residency positions have increased by 1,594.

It is wonderful to see such incredible interest in residency training and how the profession is responding to the increased demand by adding new positions. Residency training is an opportunity for pharmacists to further distinguish themselves as the medication experts on the patient care team, and expand their role in overall patient care.

ASHP, under the leadership of former CEO Dr. Joseph A. Oddis, created the concept of residency training and began accrediting programs 55 years ago. ASHP’s leadership in this area planted the seed for the formation of clinical pharmacy practice. Today, residency training and clinical pharmacy are more important than ever, and patients everywhere are benefiting from these important advances in pharmacy practice.

PGY2 ambulatory care residencies have experienced dramatic growth in recent years. Two years ago, there were 83 residency programs in ambulatory care; today there are 137 programs. Compared to last year, PGY2 residency programs in the areas of emergency medicine, infectious disease, and psychiatric care have also expanded rapidly.

The significant increase in the number of PGY2 residencies indicates that the market is demanding highly trained pharmacists for specialty areas of practice. In addition, the rising support for provider status at the state and national levels, as well as other changes to the healthcare landscape, is creating a demand for more residency programs.

Participating in residency programs is a win-win for you, your patients, and for the profession. I know that all of you as new PGY1 and PGY2 residents will rise up to meet the many challenges of completing a residency, and the experience will prepare you to practice at a higher level as a vital member of an interprofessional team.

Know that regardless of where you practice — whether in an ambulatory clinic, hospital, or other patient care setting — ASHP is your professional home as a patient care provider. Please plan to continue to read and contribute to AJHP Residents Edition. ASHP is the only organization with this exceptional peer-reviewed platform for pharmacy residents, and its success is fully attributed to you and the great work you will be doing as a resident. During your residency, keep up with best practices in research by viewing the ASHP Foundation’s The Essentials of Practice-Based Research. Please also make sure to stay involved in the ASHP New Practitioners Forum, which provides a multitude of resources and opportunities, including in-depth information about preparing for career transitions.

Again, congratulations to all of you, and good luck in your residency. I look forward to seeing you at the ASHP Midyear Clinical Meeting and Exhibition in Orlando in December!

Sincerely,

Paul

March 18, 2016

Residency Match Day 2016

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP

CONGRATULATIONS TO ALL who matched during the first of two residency Matches! For those who did not match in the First Match, please plan to participate in the Second Match, as there are still a number of unfilled positions at excellent programs for you to take advantage of.

The Match this year was another great success, with 3,940 individuals matching with residency programs. The number of residency programs continues to grow, with another 322 residency positions added to the 2016 Match. It is ASHP’s explicit goal to continue to work with residency programs and the profession to increase the number of residency positions in the years to come.

It is fantastic to see the growing interest in residency training as well as the demand for residency-trained pharmacists. Residency training has been a powerful way to help position pharmacists as knowledgeable and credible leaders on the patient care team. It has also helped pharmacists take on even greater responsibility for medication therapy management and overall patient care.

I am still amazed when I reflect on the vision that leaders like ASHP’s former CEO Dr. Joseph A. Oddis had for the profession when ASHP created the concept of residency training more than 50 years ago. I believe it is safe to say that residency training was a major driver in the evolution and advancement of pharmacy as a clinical and patient-oriented profession. We should all be thankful to those early ASHP leaders who acted on their vision for the profession many decades before residency training was in such high demand.

I know that all of you as new PGY1 and PGY2 residents will take every opportunity offered to you during this exciting and very rigorous year of training that you are about to embark on. The experience will likely be among the more challenging in your career; however, the fruits of your labor will pay great dividends in terms of the outcomes you are able to help your patients achieve and the contributions you will make as a vital member of the interprofessional team. Further, the leadership and interpersonal skills you will gain during your training will help you to be not only a leader in the profession, but also a strong advocate of the patients you serve.

Please know that regardless of where you practice — whether in an ambulatory clinic, hospital, or other patient care setting — ASHP is your professional home as a patient care provider. Also, as a resident, please plan to continue to read and contribute to AJHP Residents Edition. ASHP is the only organization with this exceptional peer-reviewed platform for pharmacy residents, and its success is fully attributed to you and the great work you will be doing as a resident. Please also make sure to stay involved in the ASHP New Practitioners Forum, which provides a multitude of resources and opportunities for you to be involved in ASHP.

Again, congratulations to all of you, and good luck in your residency. I look forward to seeing you at the ASHP Midyear Clinical Meeting in Las Vegas in December!

Paul

 

# # #

Powered by WordPress